Drugs / rZIKV/D4Δ30-713
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03611946 | Jul 2018 → Mar 2022 | Zika virus infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rZIKV/D4Δ30-713 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03611946 ↗ |